Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
Tobias Engel,1,2,* Jonathon Smith,1,2,* Mariana Alves1 1Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland; 2FutureNeuro, Science Foundation Ireland Research Centre for Chronic and...
Guardado en:
Autores principales: | Engel T, Smith J, Alves M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ca481c5656c412eb41d77b865d35985 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension
por: Mazen Shihan, et al.
Publicado: (2021) -
Purinergic Signaling in the Regulation of Gout Flare and Resolution
por: Xiaoling Li, et al.
Publicado: (2021) -
Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection
por: Victor H. Leyva-Grado, et al.
Publicado: (2017) -
The two faces of pannexins: new roles in inflammation and repair
por: Makarenkova HP, et al.
Publicado: (2018) -
Src family kinases activity is required for transmitting purinergic P2X7 receptor signaling in cortical spreading depression and neuroinflammation
por: Lingdi Nie, et al.
Publicado: (2021)